Skip to main content

Advertisement

SpringerLink
Log in

Dual-Stained Cervical Cytology and Histology with Claudin-1 and Ki67

  • Original Article
  • Published:
Pathology & Oncology Research

Abstract

Several biomarkers are in use to improve the sensitivity and specificity of cervical cancer screening. Previously, increased expression of tight junction protein claudin-1 (CLDN1) was detected in premalignant and malignant cervical lesions and applied for cytology screening. To improve the specificity, a double immunoreaction with CLDN1/Ki67 was developed in the recent study. Parallel p16/Ki67 (CINtec® PLUS) and CLDN1/Ki67 dual-stained cytology and histology were performed and compared. p16/Ki67 immunoreaction showed positivity in 317 out of 1596 smears with negativity in 1072 and unacceptable reactions in 207 samples. CLDN1/Ki67 dual staining was positive in 200 of 1358 samples, negative in 962, whereas 196 smears could not be evaluated due to technical reasons. Considering the high-grade squamous intraepithelial lesion cytology as gold standard, sensitivity of CLDN1/Ki67 reaction was 76%, specificity was 85.67%, while for p16/Ki67 sensitivity was 74% and specificity was 81.38%. Comparison of CLDN1/Ki67 and p16/Ki67 dual stainings showed the results of the two tests not to be significantly different. Analysing histological slides from 63 cases, the results of the two tests agreed perfectly. As conclusion the sensitivity and specificity proved to be similar using p16/Ki67 and CLDN1/Ki67 double immunoreactions both on LBC samples and on histological slides.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Hillemans P, Soergel P, Hertel H, Jentschke M (2016) Epidemiology and early detection of cervical cancer. Oncol Res Treat 39:1–6

    Article  Google Scholar 

  2. Sawaya GF, Smith-McCune K (2016) Cervical cancer screening. Obstet Gynecol 127:459–467

    Article  PubMed  PubMed Central  Google Scholar 

  3. Lees BF, Erickson BK, Huh WK (2016) Cervical cancer screening: evidence behind the guidelines. Am J Obstet Gynecol 214:438–443

    Article  PubMed  Google Scholar 

  4. Ocque R, Austin RM (2016) Follow-up of women with negative pap test results and abnormal clinical signs or symptoms. Am J Clin Pathol 145:560–567

    Article  PubMed  Google Scholar 

  5. Ikenberg H, Bergeron C, Schmidt D, Griesser H, Alameda F, Angeloni C, Bogers J, Dachez R, Denton K, Hariri J, Keller T, von Knebel Doeberitz M, Neumann HH, Puig-Tintore LM, Sideri M, Rehm S, Ridder R, PALMS Study Group (2013) Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study. J Natl Cancer Inst 105:1550–1557

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Wentzensen N, Fetterman B, Castle PE, Schiffman M, Wood SN, Stiemerling E, Tokugawa D, Bodelon C, Roitras N, Lorey T, Kinney W (2015) p16/Ki-67 dual stain cytology for detection of cervical precancer in HPV-positive women. J Natl Cancer Inst 107:1–8

    Article  CAS  Google Scholar 

  7. Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam S, Sasieni P, Iftner T (2006) Overview of the European and north American studies on HPV testing in primary cervical cancer screening. Int J Cancer 119:1095–1101

    Article  CAS  PubMed  Google Scholar 

  8. Plummer M, Schiffman M, Castle PE, Maucort-Boulch D, Wheeler CM, ALTS Group (2007) A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J Infect Dis 195:1582–1589

    Article  PubMed  Google Scholar 

  9. Benczik M, Galamb Á, Koiss R, Kovács A, Járay B, Székely T, Szekerczés T, Schaff Z, Sobel G, Jeney C (2016) Claudin-1 as a biomarker of cervical cytology and histology. Pathol Oncol Res 22:179–188

    Article  CAS  PubMed  Google Scholar 

  10. Bergeron C, Ikenberg H, Sideri M, Denton K, Bogers J, Schmidt D, Alameda F, Keller T, Rehm S, Ridder R, PALMS Study Group (2015) Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results. Cancer Cytopathol 123:373–381

    Article  CAS  PubMed  Google Scholar 

  11. Kocsis A, Takács T, Jeney C, Schaff Z, Koiss R, Járay B, Sobel G, Pap K, Székely I, Ferenci T, Lai HC, Nyíri M, Benczik M (2017) Performance of a new HPV and biomarker assay in management of hrHPV positive women: Subanalysis of the ongoing multicenter TRACE Clinical Trial (n>6,000) to evaluate POU4F3 as a potential biomarker of cervical precancer and cancer. Int J Cancer 140:1119–1133

    Article  CAS  PubMed  Google Scholar 

  12. Sobel G, Páska C, Szabó I, Kiss A, Kádár A, Schaff Z (2005) Increased expression of claudins in cervical squamous intraepithelial neoplasia and invasive carcinoma. Hum Pathol 36:162–169

    Article  CAS  PubMed  Google Scholar 

  13. Szabo I, Kiss A, Schaff Z, Sobel G (2009) Claudins as diagnostic and prognostic markers in gynecological cancer. Histol Histopathol 24:1607–1615

    CAS  PubMed  Google Scholar 

  14. Lee JW, Lee SJ, Seo J, Song SY, Ahn G, Park CS, Lee JH, Kim BG, Bae DS (2005) Increased expressions of claudin-1 and claudin-7 during the progression of cervical neoplasia. Gynecol Oncol 97:53–59

    Article  CAS  PubMed  Google Scholar 

  15. Lal-Nag M, Morin PJ (2009) The claudins. Genome Biol 10:235

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Nayar R, Wilbur DC (2015) The pap test and Bethesda 2014. Cancer Cytopathol 123:271–281

    Article  PubMed  Google Scholar 

  17. Solomon D (2015) Foreword. In: Nayar F, Wilbur DC (ed) The Bethesda system for reporting cervical cytology. Definitions, criteria, and explanatory notes, 3rd ed. Springer International Publishing Switzerland, Cham, pp v-vii

  18. Wentzensen N, von Knebel Doeberitz M (2007) Biomarkers in cervical cancer screening. Dis Markers 23:315–330

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Lee S, Rose MS, Sahasrabuddhe VV, Zhao R, Duggan MA (2017) Tissue-based immunohistochemical biomarker accuracy in the diagnosis of malignant glandular lesions of the uterine cervix: a systematic review of the literature and meta-analysis. Int J Gynecol Pathol 36:310–322

    Article  PubMed  PubMed Central  Google Scholar 

  20. Polman NJ, Uijterwaal MH, Witte BI, Berkhof J, van Kemenade FJ, Spruijt JW, van Baal WM, Graziosi PG, van Dijken DK, Verheijen RH, Helmerhorst TJ, Steenbergen RD, Heideman DA, Ridder R, Snijders PJ, Meijer CJ (2017) Good performance of p16/ki-67 dual-stained cytology for surveillance of women treated for high-grade CIN. Int J Cancer 140:423–430

    Article  CAS  PubMed  Google Scholar 

  21. Yu LL, Guo HQ, Lei XQ, Qin Y, Wu ZN, Kang LN, Zhang X, Qiao YL, Chen W (2016) p16/Ki-67 co-expression associates high risk human papillomavirus persistence and cervical histopathology: a 3-year cohort study in China. Oncotarget 7:64810–64819

    PubMed  PubMed Central  Google Scholar 

  22. Possati-Resende JC, Fregnani JHTG, Kerr LM, Mauad EC, Longatto-Filho A, Scapulatempo-Neto C (2015) The accuracy of p16/Ki67 and HPV test in the detection of CIN2/3 in women diagnosed with ASC-US or LSIL. PLoS One 10:e0134445

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S (1998) Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 141:1539–1550

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Morin PJ (2005) Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res 65:9603–9606

    Article  CAS  PubMed  Google Scholar 

  25. Soini Y (2005) Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours. Histopathology 46:551–560

    Article  CAS  PubMed  Google Scholar 

  26. Cunniffe C, Brankin B, Lambkin H, Ryan F (2014) The role of claudin-1 and claudin-7 in cervical tumorigenesis. Anticancer Res 34:2851–2857

    CAS  PubMed  Google Scholar 

  27. Akimoto T, Takasawa A, Murata M, Kojima Y, Takasawa K, Nojima M, Aoyama T, Hiratsuka Y, Ono Y, Tanaka S, Osanai M, Hasegawa T, Saito T, Sawada N (2016) Analysis of the expression and localization of tight junction transmembrane proteins, claudin-1, −4, −7, occludin and JAM-A, in human cervical adenocarcinoma. Histol Histopathol 31:921–931

    CAS  PubMed  Google Scholar 

  28. Győrffy H, Holczbauer Á, Nagy P, Szabó Z, Kupcsulik P, Páska C, Papp J, Schaff Z, Kiss A (2005) Claudin expression in Barrett’s esophagus and adenocarcinoma. Virchows Arch 447:961–968

    Article  CAS  PubMed  Google Scholar 

  29. Tőkés AM, Kulka J, Paku S, Szik Á, Páska C, Novák PK, Szilák L, Kiss A, Bögi K, Schaff Z (2005) Claudin-1, −3 and −4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res 7:R296–R305

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Lódi C, Szabó E, Holczbauer Á, Batmunkh E, Szíjártó A, Kupcsulik P, Kovalszky I, Paku S, Illyés G, Kiss A, Schaff Z (2006) Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas. Mod Pathol 19:460–469

    Article  CAS  PubMed  Google Scholar 

  31. Szász AM, Nyírády P, Majoros A, Szendrői A, Szűcs M, Székely E, Tőkés AM, Romics I, Kulka J (2010) Beta-catenin expression and claudin expression pattern as prognostic factors of prostatic cancer progression. BJU Int 105:716–722

    Article  CAS  PubMed  Google Scholar 

  32. English DP, Santin AD (2013) Claudins overexpression in ovarian cancer: potential targets for Clostridium Perfringens enterotoxin (CPE) based diagnosis and therapy. Int J Mol Sci 14:10412–10437

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Vázquez-Ortíz G, Ciudad CJ, Pina P, Vazquez K, Hidalgo A, Latorre B, Garcia JA, Salamanca F, Peralta-Rodriguez R, Rangel A, Salcedo M (2005) Gene identification by cDNA arrays in HPV-positive cervical cancer. Arch Med Res 36:448–458

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This work was supported by grant #NKFP_07_2-SPE-SAFE, Jedlik Ányos 2. subprogram KMR_12–1–2012-0032 by the Hungarian National Research and Development Fund and grant #OTKA PD105019 by the Hungarian National Research Foundation.

Author information

Author notes

  1. Tímea Szekerczés and Ádám Galamb equally contributed

Authors and Affiliations

  1. 2nd Department of Pathology, Semmelweis University, Üllői út 93, Budapest, H-1091, Hungary

    Tímea Szekerczés, Balázs Járay, András Kiss & Zsuzsa Schaff

  2. 2nd Department of Obstetrics and Gynecology, Semmelweis University, Budapest, Hungary

    Ádám Galamb, Attila Martonos & Gábor Sobel

  3. Cellcall Ltd., Budapest, Hungary

    Adrienn Kocsis, Márta Benczik, Tibor Takács, Csaba Jeney & Miklós Nyíri

  4. NEUMANN Diagnostics Ltd., Budapest, Hungary

    Adrienn Kocsis, Márta Benczik, Tibor Takács & Miklós Nyíri

  5. SYNLAB Hungary Ltd., GenoID Molecular Diagnostic Laboratory, Budapest, Hungary

    Márta Benczik & Tibor Takács

  6. Department of Medical Microbiology, Semmelweis University, Budapest, Hungary

    Csaba Jeney

Authors
  1. Tímea Szekerczés
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ádám Galamb
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Adrienn Kocsis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Márta Benczik
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tibor Takács
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Attila Martonos
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Balázs Járay
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. András Kiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Csaba Jeney
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Miklós Nyíri
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Zsuzsa Schaff
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Gábor Sobel
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

TSz performed and evaluated the immunreactions and statistics, ÁG and AM collected the clinical samples and data, BJ and AKi evaluated the cytology, ZsS and GS designed and coordinated the study and wrote the manuscript. AKo and MB are clinical experts of the TRACE clinical study (Cellcall). TT is the inventor of the HPV detection technology applied in the CONFIDENCE HPV™ (NEUMANN Diagnostics) testing. CsJ was former head of the TRACE clinical study (Cellcall). ZsS accepts full responsibility for the work. All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Zsuzsa Schaff.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest with respect to the research, authorship, and/or publication of this article.

AKo is an employee of Cellcall and NEUMANN. MB receives consultancy fees from Cellcall and NEUMANN, she is an employee of SYNLAB GenoID Laboratory, which participated in the TRACE clinical study (all related expenses were charged to Cellcall and NEUMANN). TT is a part time employee of Cellcall, he receives consultancy fees from NEUMANN, he is minority owner of NEUMANN, the inventor of the HPV detection technology described in the manuscript covering which Cellcall submitted a patent application (license now owned by NEUMANN Diagnostics Ltd.); he is a part time employee of SYNLAB GenoID Laboratory. CsJ was a former employee of Cellcall. MNy is an employee of Cellcall and NEUMANN.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Szekerczés, T., Galamb, Á., Kocsis, A. et al. Dual-Stained Cervical Cytology and Histology with Claudin-1 and Ki67. Pathol. Oncol. Res. 25, 477–486 (2019). https://doi.org/10.1007/s12253-018-0384-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-018-0384-x

Keywords

Search

Navigation